Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
43
GSK Quote, Financials, Valuation and Earnings
Last price:
$39.54
Seasonality move
:
4.92%
Day range:
$40.11 - $40.39
52-week range:
$31.72 - $45.93
Dividend yield:
3.85%
P/E ratio:
25.51x
P/S ratio:
2.08x
P/B ratio:
4.80x
Volume:
3.7M
Avg. volume:
5.6M
1-year change:
-4.15%
Market cap:
$82.3B
Revenue:
$40.1B
EPS (TTM):
$1.58
Earnings Data
Next earnings date for GSK
Apr 30
2025
Most recent earnings per share
$0.26
Missed by $0.23
(Feb 5/2025)
Consensus Estimate
$0.49
(Feb 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GSK Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 04/30/2025 | Q1 | $9.7B | -- | -- | $1.01 | -- |
| 02/05/2025 | Q4 | $9.6B | $10.4B | $0.26 | $0.49 | -$0.23 |
| 10/30/2024 | Q3 | $10.4B | $10.4B | -$0.04 | $1.16 | -$1.20 |
| 07/31/2024 | Q2 | $9.6B | $9.9B | $0.72 | $0.98 | -$0.27 |
| 05/01/2024 | Q1 | $8.8B | $9.3B | $0.64 | $0.94 | -$0.29 |
| 01/31/2024 | Q4 | $9.7B | $10B | $0.21 | $0.77 | -$0.56 |
| 11/01/2023 | Q3 | $9.4B | $10.3B | $0.90 | $1.14 | -$0.24 |
| 07/26/2023 | Q2 | $8.8B | $9B | $0.99 | $0.87 | $0.12 |
| 04/26/2023 | Q1 | $8.2B | $8.4B | $0.89 | $0.82 | $0.06 |
| 02/01/2023 | Q4 | $8.8B | $8.7B | $0.86 | $0.55 | $0.31 |
| 11/02/2022 | Q3 | -- | $9.2B | $6.23 | -- | -- |
| 07/27/2022 | Q2 | -- | $8.7B | $0.41 | -- | -- |
| 04/27/2022 | Q1 | -- | $9.6B | $1.19 | -- | -- |
| 02/09/2022 | Q4 | -- | $9.5B | $0.50 | -- | -- |
| 10/27/2021 | Q3 | -- | $9.1B | $0.79 | -- | -- |
| 07/28/2021 | Q2 | -- | $8.2B | $0.96 | -- | -- |
| 04/28/2021 | Q1 | -- | $10.2B | $0.73 | -- | -- |
| 02/03/2021 | Q4 | -- | -$1.3B | $0.44 | -- | -- |
| 10/28/2020 | Q3 | -- | $11.2B | $0.80 | -- | -- |
| 07/29/2020 | Q2 | -- | $9.5B | $1.40 | -- | -- |
| 04/29/2020 | Q1 | -- | $11.7B | $1.00 | -- | -- |
| 02/05/2020 | Q4 | -- | $11.5B | $0.83 | -- | -- |
| 10/30/2019 | Q3 | -- | $11.6B | $0.95 | -- | -- |
| 07/24/2019 | Q2 | -- | $10B | $0.62 | -- | -- |
| 05/01/2019 | Q1 | -- | $10B | $0.54 | -- | -- |
| 02/06/2019 | Q4 | -- | $10.5B | $0.78 | -- | -- |
| 10/31/2018 | Q3 | -- | $10.5B | $0.93 | -- | -- |
| 07/25/2018 | Q2 | -- | $10B | $0.30 | -- | -- |
| 04/25/2018 | Q1 | -- | $10B | $0.39 | -- | -- |
| 02/07/2018 | Q4 | -- | $10.1B | -$0.37 | -- | -- |
| 10/25/2017 | Q3 | -- | $10.3B | $0.81 | -- | -- |
| 07/26/2017 | Q2 | -- | $9.4B | -$0.12 | -- | -- |
| 04/26/2017 | Q1 | -- | $9.1B | $0.66 | -- | -- |
| 02/08/2017 | Q4 | -- | $9.4B | $0.16 | -- | -- |
| 10/26/2016 | Q3 | -- | $9.9B | $0.54 | -- | -- |
| 07/27/2016 | Q2 | -- | $9.4B | -$0.32 | -- | -- |
| 04/27/2016 | Q1 | -- | $8.9B | $0.21 | -- | -- |
| 02/03/2016 | Q4 | -- | $9.5B | -$0.28 | -- | -- |
| 10/28/2015 | Q3 | -- | $9.5B | $0.43 | -- | -- |
| 07/29/2015 | Q2 | -- | $9B | $0.12 | -- | -- |
| 05/06/2015 | Q1 | -- | $8.5B | $6.31 | -- | -- |
GSK PLC Earnings Questions
-
How Much did GSK PLC Generate in Revenue Last Quarter?
GSK PLC reported $10.4B worth of top line sales in its most recent quarter.
-
Did GSK PLC Beat Earnings Last Quarter?
GSK PLC announced earnings per share of $0.26 which represents a miss of analyst forecast a $0.49 per share.
-
Is GSK PLC Profitable?
GSK PLC reported $7.1B that represents $3.42 per share over the last quarter.
-
What is the Analyst Consensus for GSK PLC EPS Next Year?
GSK PLC's earnings are forecast to grow from $1.59 per share to $3.92 per share next year representing an increase of 168.25%.
-
When is GSK PLC's Earnings Date?
GSK PLC's next earnings date is April 30, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
52
RGC alert for Mar 19
Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 8.72% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5.74% over the past day.
